Pharma Biotech Congress Market Analysis and Reports | Singapore Conference Series

Market Analysis - Pharma Biotech Congress 2019

The Global Biopharmaceutical Market is poised to grow at a CAGR of around 10.1% over the next decade to reach approximately $459.81 billion by 2025.The opportunity in biopharmaceuticals is big and growing too rapidly to ignore. Today biopharmaceuticals generate global revenues of $163 billion, making up about 20%of the Pharma market. It’s by far the fastest-growing part of the industry. Biopharma’s current annual growth rate of more than 8% is double that of conventional Pharma, and growth is expected to continue at that rate for the foreseeable future.

It is estimated at USD 215 million for the year 2017 and is projected to reach USD 269 billion by the year 2021. The estimated CAGR during the forecast period (2017-2021) is 5.76%.

As the Japanese Pharma economy is in a state of transition towards greater openness, potential rewards for early international movers were cited as another key factor in the rapid shifts predicted in 2018.

The pharmaceutical market in Japan is set to rise from around $70 billion in 2016 to $72 billion by 2021, representing a low compound annual growth rate of 0.3%, according to Global Data, a recognized leader in providing business information and analytics.

Japan represents the world’s eighth biggest market for generic drugs in terms of value. Generic drugs, however, have traditionally enjoyed a relatively lower penetration in Japan compared to other developed markets such as the United States and Europe.

The Japanese government has identified growth of the country’s generic drug market as imperative to Japan’s long-term economic health

The penetration of generics has grown robustly over the past few years. The government has also made a target towards achieving a generic penetration of 60% by 2018. This is expected to create huge opportunities for both domestic and foreign generic manufacturers in Japan.

The biggest change for Pharma in Japan was the 2014 revision of the nation’s keystone pharmaceuticals law, renamed the PMD Act—for pharmaceutical and medical devices. Japanese officials proudly say some drug approvals in Japan are now faster than in both Europe and the U.S.—a marked change from the days when Japan was seen as a difficult market for foreign companies.

Related Associations or Societies: Pharmaceutical Society of IrelandThe International Society for Pharmaceutical Engineering (ISPE), European Association of Employed Community Pharmacists in Europe (EPhEU), Pharmaceutical Group of the European Union (PGEU).Accreditation Council for Pharmacy Education (ACPE), Association of British Healthcare Industries (ABHI), Association of the British Pharmaceutical Industry (ABPI), National Pharmacy Association (NPA), Dutch Society for Clinical Pharmacology & BiopharmacyEuropean Association of Clinical Pharmacology and Therapeutics (EACPT), Japan Pharmaceutical AssociationJapan Society of Drug Delivery System, American Association of Pharmaceutical Scientists-AAPS, The Japanese Society of PharmacognosyJapanese Pharmacological SocietyPharmacological Society of TaiwanPharmaceutical Society of KoreaPharmaceutical Society of Australia, Parenteral Drug AssociationChinese Biopharmaceutical AssociationChinese American Biopharmaceutical SocietyJapanese Society For BioinformaticsJapan Bioindustry AssociationThe Society for Biotechnology Japan, Japan Society for Bioscience, Biotechnology, and Agro chemistryThe Photobiology Association of JapanJapanese Society for Plant Cell and Molecular BiologyJapanese Society for Marine Biotechnology, Japan Pharmaceutical Manufacturers Association(JPMA), Swiss Biotech Association

Related Biopharmaceutics Conferences | Biopharmaceutics Meetings | Pharma Biotech Conference | Biotechnology Conferences 


9th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25- 26, 2019 Berlin, Germany, World Congress on Pharmaceutical Biotechnology & Bioengineering March 25-26, 2019 Orlando, Florida, USA, 11th World Congress on Pharmacology & Therapeutics April 17-18, 2019 Montreal, Canada, 2nd International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine March 20-21, 2019 New York , USA, 8th International Conference on Clinical Trials September 11-13, 2019 | Orlando, Florida, USA, World Congress on Pharmaceutical Biotechnology March 25-26, 2019 Orlando, Florida, US, Digi Pharma Connect February 27 - March 01, 2019, Austin, Texas, 17th  Annual eyeforpharma April 2019, Philadelphia.


17th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 18-20, 2019 Scotland, UK, 15th International Conference and Exhibition on Nanomedicine and Pharmaceutical NanotechnologyMarch 18-19, 2019 Paris, France, 2 th European Biosimilars Congress April 15-16, 2019 Berlin, Germany, 16th Annual European Pharma Congress May 20-21, 2019 Zurich, Switzerland, 3rd Global Pharmaceutical Expo and ConferenceJuly 03-05, 2019, London UK, Europe’s End-to-End Pharma Procurement Event 19 - 20 March, 2019, Frankfurt, 2ndWorld Congress on Pharmaceutical and Chemical Sciences July 23-25, 2018, bologna, Italy

Asia Pacific:

2nd Annual Pharmaceutical Biotechnology Congress May 06-07, 2019 Tokyo, Japan, Pharmatech 2019 May 22-23 2019 Sydney, Australia, 6th World Congress on Advanced Clinical Trials and Clinical Research May 06-07, 2019 Brisbane, Australia, 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, 22nd World Congress on Biotechnology November 19-20, 2018 Bangkok, Thailand; International Biotechnology and Health Care Convention - October 5 - 6, 2018 Osaka, Japan, 11thAsia Pacific Global Summit on Healthcare May 08-09, 2019 Tokyo, Japan, 4th International Conference on Biochemistry & Molecular Biology May 10-11, 2019 Tokyo, Japan, 13thInternational conference on Proteomics Genomics and Bioinformatics May 10-11, 2019 Tokyo, Japan. 12th Asian Biologics and Biosimilars Congress August 20-21, 2018 Tokyo, Japan, 12thINT’L pharmaceutical Ingredients ExpoJune 27- 29, 2018, Tokyo, Japan, CPhI Japan 18 - 20 March 2019 Tokyo, Japan

Middle East:

6th World Congress on Drug Discovery & Toxicology April 22-23, 2019 Abu Dhabi, UAE, 12th International Conference on Pharmacoepidemiology and Clinical Research December 13-14, 2018 Abu Dhabi, UAE, 10th World Congress on Bioavailability & Bioequivalence April 08-10, 2019 Abu Dhabi, UAE, Med Lab 4 – 7 February 2019, Dubai, UAE, CPhl Middle east& Africa 3-5 September 2018 ADNEC, Abu Dhabi, UAE

Conference series llc LTD proudly announces the commencement of “2ndAnnual Pharmaceutical Biotechnology Congress” which is going to be held during May 06-07, 2019 at TokyoJapan.

Pharma Biotech Congress 2019 focuses upon “Comprehensive Innovations and Researches in Pharmaceutical Biotechnology”.  This Pharma Biotech Congress 2019 focuses on the trends which the biopharmaceutical market is heading on since its launch till the present date and moving on to the projections in future. It takes into its fold the critical developmental procedures, analyses, regulatory factors and also pharmacovigilance including post marketing surveillance and clinical studies. Innovation and compliance to regulatory guidelines are the most critical aspects towards biosimilars and follow on biologics development and successful launching to the market.